Skip to content
Search

Latest Stories

GP appointments hit record high despite workforce crisis

October data shows that general practice in England delivered 41.3 million appointments

The number of fully-qualified GPs is steadily increasing, but it’s still fewer than five years ago   

General practice has delivered a record number of appointments despite the workforce crisis, but health leaders warn it is “not sustainable.”

NHS England's latest workforce and appointment data shows that general practice delivered 41.3 million appointments, marking an increase of 3 million compared to last year's record and a significant rise of 10 million from five years ago.


The number of fully-qualified, full-time equivalent (FTE) GPs rose to 28,031 in October, reflecting a 2.4 per cent (663) increase compared to October 2023.

However, Professor Kamila Hawthorne, chair of the Royal College of GPs (RCGP), pointed out that the workforce still has “nearly 100 fewer fully qualified, full-time equivalent GPs” than in 2019.

“Whilst this shows the dedication of GPs and our teams to ensure patients receive the care they need, it is not sustainable,” she said, expressing concern that the mounting workload is leading many GPs to experience burnout.

A recent RCGP survey revealed that over 40 per cent of GPs are unlikely to remain in general practice in five years, with more than half saying they find the job ‘too stressful.’

Professor Hawthorne also referenced the Lord Darzi review, which acknowledged that primary care consistently delivers more care, with a shrinking proportion of the NHS budget.

She warned that rising pressures on general practice are affecting patient access to care.

“We’ve heard some encouraging proposals from the new government to move more resource into primary care, but the pressures remain – and worsen – month by month, and it is our most vulnerable patients who are bearing the brunt when they struggle to access our care,” she said.

“With winter fast approaching, our services will only get busier – and uncertainty around how the hike in National Insurance for employers will impact practices is only adding to the pressures general practice is facing.”

“We need action now to alleviate the workforce crisis,” Professor Hawthorne continued, calling for urgent investment in general practice, including schemes to recruit and retain GPs to maintain the high-quality care patients deserve.

Jake Beech, Health Foundation policy fellow, noted that the workforce crisis is contributing to declining patient satisfaction.

“These numbers speak to the huge effort that has gone into meeting the high level of demand for primary care, but need to be seen within the context of declining patient satisfaction and high numbers of GPs struggling to manage overwhelming patient demand,” he said.

NHSE data shows that the number of fully qualified, permanent FTE GPs was 27,519 in October 2024, compared to 28,590 in September 2015.

“Although the expansion of other staff working in general practice – like pharmacists and paramedics – has helped to expand the number of appointments available, these staff cannot replace GPs who are responsible for managing the most complex cases.

“If the government is serious about its ambitions to move care out of hospital and into primary care then it needs to ensure general practice is given the resources it needs to recruit and retain more GPs, especially in the most deprived areas which are particularly under-doctored,” he added.

Beech also called for greater investment in training and staff development, as well as creating the right conditions to retain workers.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less